{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:02:19Z","timestamp":1785211339291,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s12031-022-02035-5","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T19:02:25Z","timestamp":1654714945000},"page":"1715-1723","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Unique Ataxia-Oculomotor Apraxia 2 (AOA2) in Israel with Novel Variants, Atypical Late Presentation, and Possible Identification of a Poison Exon"],"prefix":"10.1007","volume":"72","author":[{"given":"Penina","family":"Ponger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Kurolap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israela","family":"Lerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Dagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chofit","family":"Chai Gadot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Mory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Wilnai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nino","family":"Oniashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Giladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Gurevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vardiella","family":"Meiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lossos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagit","family":"Baris Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,8]]},"reference":[{"key":"2035_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s10048-009-0206-0","author":"G Airoldi","year":"2010","unstructured":"Airoldi G, Guidarelli A, Cantoni O et al (2010) Characterization of two novel SETX mutations in AOA2 patients reveals aspects of the pathophysiological role of senataxin. Neurogenetics. https:\/\/doi.org\/10.1007\/s10048-009-0206-0","journal-title":"Neurogenetics"},{"key":"2035_CR2","doi-asserted-by":"publisher","DOI":"10.5582\/irdr.2018.01107","author":"H Algahtani","year":"2018","unstructured":"Algahtani H, Shirah B, Algahtani R et al (2018) Ataxia with ocular apraxia type 2 not responding to 4-aminopyridine: a rare mutation in the SETX gene in a Saudi patient. Intractable Rare Dis Res. https:\/\/doi.org\/10.5582\/irdr.2018.01107","journal-title":"Intractable Rare Dis Res"},{"key":"2035_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp211","author":"M Anheim","year":"2009","unstructured":"Anheim M, Monga B, Fleury M et al (2009) Ataxia with oculomotor apraxia type 2: clinical, biological and genotype\/phenotype correlation study of a cohort of 90 patients. Brain. https:\/\/doi.org\/10.1093\/brain\/awp211","journal-title":"Brain"},{"key":"2035_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s10048-008-0139-z","author":"L Arning","year":"2008","unstructured":"Arning L, Sch\u00f6ls L, Cin H et al (2008) Identification and characterisation of a large senataxin (SETX) gene duplication in ataxia with ocular apraxia type 2 (AOA2). Neurogenetics. https:\/\/doi.org\/10.1007\/s10048-008-0139-z","journal-title":"Neurogenetics"},{"key":"2035_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkg616","author":"L Cartegni","year":"2003","unstructured":"Cartegni L, Wang J, Zhu Z et al (2003) ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkg616","journal-title":"Nucleic Acids Res"},{"key":"2035_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2020.05.030","author":"GL Carvill","year":"2020","unstructured":"Carvill GL, Mefford HC (2020) Poison exons in neurodevelopment and disease. Curr Opin Genet Dev. https:\/\/doi.org\/10.1016\/j.gde.2020.05.030","journal-title":"Curr Opin Genet Dev"},{"key":"2035_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02894-w","author":"S Cohen","year":"2018","unstructured":"Cohen S, Puget N, Lin Y et al (2018) Senataxin resolves RNA:DNA hybrids forming at DNA double-strand breaks to prevent translocations. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-018-02894-w","journal-title":"Nat Commun"},{"key":"2035_CR8","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000208402.10512.4a","author":"C Criscuolo","year":"2006","unstructured":"Criscuolo C, Chessa L, Di Giandomenico S et al (2006) Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study. Neurology. https:\/\/doi.org\/10.1212\/01.wnl.0000208402.10512.4a","journal-title":"Neurology"},{"key":"2035_CR9","doi-asserted-by":"publisher","DOI":"10.3109\/00207454.2013.787616","author":"N Datta","year":"2013","unstructured":"Datta N, Hohler A (2013) A new SETX mutation producing AOA2 in two siblings. Int J Neurosci. https:\/\/doi.org\/10.3109\/00207454.2013.787616","journal-title":"Int J Neurosci"},{"key":"2035_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkg616","author":"FO Desmet","year":"2009","unstructured":"Desmet FO, Hamroun D, Lalande M et al (2009) Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkg616","journal-title":"Nucleic Acids Res"},{"key":"2035_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu190","author":"B Fogel","year":"2014","unstructured":"Fogel B, Cho E, Wahnich A et al (2014) Mutation of senataxin alters disease-specific transcriptional networks in patients with ataxia with oculomotor apraxia type 2. Hum Mol Genet. https:\/\/doi.org\/10.1093\/hmg\/ddu190","journal-title":"Hum Mol Genet"},{"key":"2035_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2010.09.004","author":"J Gazulla","year":"2010","unstructured":"Gazulla J, Benavente I, P\u00e9rez L\u00f3pez-Fraile I et al (2010) Sensory neuronopathy in ataxia with oculomotor apraxia type 2. J Neurol Sci. https:\/\/doi.org\/10.1016\/j.jns.2010.09.004","journal-title":"J Neurol Sci"},{"key":"2035_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2017.12.030","author":"C Grunseich","year":"2018","unstructured":"Grunseich C, Wang I, Watts J et al (2018) Senataxin mutation reveals how r-loops promote transcription by blocking DNA methylation at gene promoters. Mol Cell. https:\/\/doi.org\/10.1016\/j.molcel.2017.12.030","journal-title":"Mol Cell"},{"key":"2035_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.12.015","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan K, Panagiotopoulou SK, McRae JF et al (2019) Predicting splicing from primary sequence with deep learning. Cell. https:\/\/doi.org\/10.1016\/j.cell.2018.12.015","journal-title":"Cell"},{"key":"2035_CR15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2114314119","author":"R Kanagaraj","year":"2022","unstructured":"Kanagaraj R, Mitter R, Kantidakis T et al (2022) Integrated genome and transcriptome analyses reveal the mechanism of genome instability in ataxia with oculomotor apraxia 2. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2114314119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2035_CR16","doi-asserted-by":"publisher","DOI":"10.4161\/rdis.25230","author":"M Lavin","year":"2013","unstructured":"Lavin M, Yeo A, Becherel O (2013) Senataxin protects the genome, implications for neurodegeneration and other abnormalities. Rare Diseases. https:\/\/doi.org\/10.4161\/rdis.25230","journal-title":"Rare Diseases"},{"key":"2035_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.11.074","author":"E Motokura","year":"2017","unstructured":"Motokura E, Yamashita T, Takahashi Y et al (2017) An AOA2 patient with a novel compound heterozygous SETX frame shift mutations. J Neurol Sci. https:\/\/doi.org\/10.1016\/j.jns.2016.11.074","journal-title":"J Neurol Sci"},{"key":"2035_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/238731","author":"A Oostra","year":"2012","unstructured":"Oostra A, Nieuwint A, Joenje H et al (2012) Diagnosis of Fanconi anemia: chromosomal breakage analysis. Anemia. https:\/\/doi.org\/10.1155\/2012\/238731","journal-title":"Anemia"},{"key":"2035_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2014.10.024","author":"J Pera","year":"2015","unstructured":"Pera J, Lechner S, Biskup S et al (2015) Two novel mutations of the SETX gene and ataxia with oculomotor apraxia type 2. Clin Neurol Neurosurg. https:\/\/doi.org\/10.1016\/j.clineuro.2014.10.024","journal-title":"Clin Neurol Neurosurg"},{"key":"2035_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30033-X","author":"J Rexach","year":"2019","unstructured":"Rexach J, Lee H, Martinez-Agosto JA et al (2019) Clinical application of next-generation sequencing to the practice of neurology. Lancet Neurol. https:\/\/doi.org\/10.1016\/S1474-4422(19)30033-X","journal-title":"Lancet Neurol"},{"key":"2035_CR21","doi-asserted-by":"crossref","unstructured":"Screaton GR, C\u00e1ceres JF, Mayeda A et al (1995) Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J 14(17):4336\u201349","DOI":"10.1002\/j.1460-2075.1995.tb00108.x"},{"key":"2035_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-015-0569-y","author":"L Szpisjak","year":"2016","unstructured":"Szpisjak L, Obal I, Engelhardt J et al (2016) A novel SETX gene mutation producing ataxia with oculomotor apraxia type 2. Acta Neurol Belg. https:\/\/doi.org\/10.1007\/s13760-015-0569-y","journal-title":"Acta Neurol Belg"},{"key":"2035_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2016-10425923","author":"A Ta-Shma","year":"2017","unstructured":"Ta-Shma A, Zhang K, Salimova E et al (2017) Congenital valvular defects associated with deleterious mutations in the. J Med Genet. https:\/\/doi.org\/10.1136\/jmedgenet-2016-10425923","journal-title":"J Med Genet"},{"key":"2035_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2013.10.003","author":"C Vantaggiato","year":"2014","unstructured":"Vantaggiato C, Cantoni O, Guidarelli A et al (2014) Novel SETX variants in a patient with ataxia, neuropathy, and oculomotor apraxia are associated with normal sensitivity to oxidative DNA damaging agents. Brain Dev. https:\/\/doi.org\/10.1016\/j.braindev.2013.10.003","journal-title":"Brain Dev"},{"key":"2035_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/uog.24885","author":"Y Yaron","year":"2022","unstructured":"Yaron Y, Ofen Glassner V, Mory A et al (2022) Exome sequencing as a first-tier test for fetuses with severe central nervous system structural anomalies. Ultrasound Obstet Gynecol. https:\/\/doi.org\/10.1002\/uog.24885","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-022-02035-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-022-02035-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-022-02035-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T03:52:07Z","timestamp":1660362727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-022-02035-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,8]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["2035"],"URL":"https:\/\/doi.org\/10.1007\/s12031-022-02035-5","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,8]]},"assertion":[{"value":"11 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}